Basilar artery occlusive disease has heterogenous clinical presentations and carries a high risk of morbidity and mortality.Treatment strategies have not been proved by large prospective randomised clinical trials due to infrequency and various presentations.Management of the patient can be designated based on clinical and radiological findings and underlying eatiologies.